Translational Medicine

Research Frontiers in Myeloid-Derived Suppressor Cell Targeting

Development of strategies to deplete or reprogram immunosuppressive myeloid populations to enhance anti-tumor immune responses in cancer immunotherapy.

All Translational Medicine PhD categories